Circulating interleukin 6 and interleukin 10 in community acquired pneumonia

Thorax

Volumn 54, Issue 1, 1999, Pages 51-55

  Glynn, P ^a   Coakley, R ^a   Kilgallen, I ^a   Murphy, N ^a   O'Neill, S ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Community acquired pneumonia; Interleukin 10; Interleukin 6

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032940116     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.1.51     Document Type: Article

References (25)

1. Torres A, Serra-Battles J, Ferrer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991;144:312-8.
2. Calandra T, Gerain J, Heumann D, et al and the Swiss-Dutch J5 Immunoglobulin Study Group. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value and interplay with other cytokines. Am J Med 1991;91:23-9.
3. Cannon JG, Tompkins RG, Gelfland JA, et al. Circulating interleukin-1 and tumour necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;160:79-84.
4. Endo S, Inada K, Inoue Y, et al. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circulatory Shock 1992;38L:264-74.
5. Martin C, Sauzx P, Mege JL, et al. Prognostic value of serum cytokines in septic shock. Intensive Care Med 1994;20:272-7.
6. Knaus WA, Draper EA, Douglas PW, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
7. Damas P, Ledoux D, Nys M, et al. Cytokine serum levels during severe sepsis in humans: IL-6 as a marker of severity. Ann Surg 1992;215:356-62.
8. Dehoux M, Boutten A, Ostinelli J, et al. Compartmentalised cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994;150:710-6.
9. Puren J, Feldman C, Savage N, et al. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995;107:1342-9.
10. De Waal Malefyt, Abrams RJ, Bennett B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
11. Andrew F, Riordan I, Marzouk O, et al. Proinflammatory and anti-inflammatory cytokines in meningococcal disease. Arch Dis Child 1996;75:453-4.
12. Marchant A, Deviere J, Byl B, et al. Interleukin-10 production during septicaemia. Lancet 1994;343:707-8.
13. Jiminez J, Martin MC, Sauri R, et al. Interkeukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 1995;171:472-5.
14. van der Poll T, de Waal Malefyt R, Coyle SM, et al. Anti-inflammatory cytokine response during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10 and IL-13. J Infect Dis 1997;175:118-22.
15. Donnelly S, Strieter R, Reid P, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fields of patients with the adult respiratory distress syndrome. Ann Intern Med 1996;125:191-6.
16. de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumour necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock and bacterial pneumonia. Crit Care Med 1997;25:607-13.
17. Venkatesan P, Gladman J, Macfarlane JT, et al. A hospital study of community acquired pneumonia in the elderly. Thorax 1990;45:254-8.
18. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-73.
19. Inamizu T, Chang M, Makinodan T. Influence of age on the production and regulation of interleukin-1 in mice. Immunology 1985;55:447.
20. Polignano A, Torterella C, Venezia A, et al. Age-associated changes of neutrophil responsiveness in a human elderly population. Cytobios 1994;80:144-53.
21. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
22. Doughty L, Kaplan S, Carcillo J. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 1996;24:1137-43.
23. Cassatella MA, Meda L, Bonora S, et al. IL-10 inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumour necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
24. Boutten A, Dehoux M, Seta N, et al. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996;153:336-42.
25. Cox G. IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol 1996;271:L566-71.